Neuland Laboratories spurts as Hyderabad unit clears USFDA inspection
Mumbai, March 22 -- The USFDA had conducted the inspection from 18 March 2024 to 22 March 2024 at company's unit 1 manufacturing facility at Bonthapally, Hyderabad.
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and nternational markets.
The company reported a consolidated net profit of Rs 81.39 crore in Q3 FY24, steeply higher than Rs 30.55 crore posted in Q3 FY23. Net sales jumped 45.9% year on year to Rs 392.83 crore in Q3 FY23.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.